<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39407877</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>29</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>How Long Is Long COVID? Evaluation of Long-Term Health Status in Individuals Discharged from a Specialist Community Long COVID Service.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5817</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13195817</ELocationID><Abstract><AbstractText><b>Background:</b> Post COVID-19 syndrome or long COVID (LC) is a novel fluctuating condition with a protracted course in some patients. Specialist LC services have been operational in the UK since 2020 and deal with a high caseload of patients. <b>Aims:</b> To evaluate long-term outcomes in patients discharged from a community-based LC specialist service. <b>Methods:</b> A service evaluation study that included patients who were well engaged in the services [completed the standard Patient Reported Outcome Measures (PROMs) and received intervention from clinician(s)] and had been discharged for at least 3 months from the service. They consented to the study and completed standard PROMs: COVID-19 Yorkshire Rehabilitation Scale (C19-YRS), EQ-5D-5L and National Institute for Health and Care Excellence (NICE) criteria for myalgia encephalomyelitis/chronic fatigue syndrome (ME/CFS). <b>Results:</b> Out of 460 patients contacted, 112 (average of 37.6 months since infection and 9.8 months post-discharge) completed the PROMs. Of these, 90.2% patients continued to experience LC symptoms and disability and had not returned to their pre-COVID-19 health status. The average EQ-5D-5L index score was 0.53 (SD 0.29), highlighting a significant disability and that LC had become a long-term condition (LTC) in the majority of patients who responded to the survey. Of these patients, 43% met the criteria for suspected ME/CFS. <b>Conclusions:</b> A proportion of LC patients develop persistent long COVID (PLC) consistent with a LTC and had a significant overlap with ME/CFS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bodey</LastName><ForeName>Rochelle</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Leeds Long COVID Community Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grimaldi</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Leeds Long COVID Community Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tait</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Leeds Long COVID Community Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Godfrey</LastName><ForeName>Belinda</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Leeds Long COVID Community Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Witton</LastName><ForeName>Sharon</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Leeds Long COVID Community Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shardha</LastName><ForeName>Jenna</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Leeds Long COVID Community Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tarrant</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Leeds Long COVID Community Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Leeds Long COVID Community Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Demonstration Centre of Rehabilitation Medicine, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academic Department of Rehabilitation Medicine, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Martin Wing, Leeds General Infirmary, Leeds LS1 3EX, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">post-acute infection syndrome (PAIS)</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407877</ArticleId><ArticleId IdType="pmc">PMC11477015</ArticleId><ArticleId IdType="doi">10.3390/jcm13195817</ArticleId><ArticleId IdType="pii">jcm13195817</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK&#x2014;Office for National Statistics.  [(accessed on 9 April 2024)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023.</Citation></Reference><Reference><Citation>Davis H.E., Assaf G.S., Mccorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Eclinicalmedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Robineau O., Zins M., Touvier M., Wiernik E., Lemogne C., De Lamballerie X., Blanch&#xe9; H., Deleuze J., Villarroel P., Dorival C., et al. Long-lasting Symptoms After an Acute COVID-19 Infection and Factors Associated With Their Resolution. JAMA Netw. Open. 2022;5:11. doi: 10.1001/jamanetworkopen.2022.40985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.40985</ArticleId><ArticleId IdType="pmc">PMC9647489</ArticleId><ArticleId IdType="pubmed">36350653</ArticleId></ArticleIdList></Reference><Reference><Citation>Demko Z.O., Yu T., Mullapudi S.K., Varela Heslin M.G., Dorsey C.A., Payton C.B., Blair P.W., Mehta S.H., Thomas D.L., Manabe Y.C., et al. Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6&#x2013;12 Months Postinfection. Open Forum Infect. Dis. 2024;11:ofae027. doi: 10.1093/ofid/ofae027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofae027</ArticleId><ArticleId IdType="pmc">PMC10917418</ArticleId><ArticleId IdType="pubmed">38449921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Greenwood D., Smith A., Rocha Lawrence R., Osborne T., Goodwin M. A National Evaluation of Outcomes in Long COVID Services Using Digital PROM Data from the ELAROS Platform. LOCO-MOTION and ELAROS, Published by NHS England, 2023.  [(accessed on 28 September 2024)].  Available online:  https://locomotion.leeds.ac.uk/wp-content/uploads/sites/74/2023/10/National-Evaluation-of-LC-Service-Outcomes-using-ELAROS-Data-09-10-23.pdf.</Citation></Reference><Reference><Citation>Joint Report by TUC and Long COVID Support, March 2023.  [(accessed on 23 April 2024)].  Available online:  https://www.tuc.org.uk/research-analysis/reports/workers-experience-long-covid.</Citation></Reference><Reference><Citation>CIPD Report: Health and Wellbeing at Work.  [(accessed on 23 April 2024)].  Available online:  https://www.cipd.org/uk/knowledge/reports/health-well-being-work.</Citation></Reference><Reference><Citation>Demko Z.O., Yu T., Mullapudi S.K., Heslin M.G.V., Dorsey C.A., Payton C.B., Tornheim J.A., Blair P.W., Mehta S.H., Thomas D.L., et al. Post-acute sequelae of SARS-CoV-2 (PASC) impact quality of life at 6, 12 and 18 months post-infection. medRxiv. 2022;9 doi: 10.1101/2022.08.08.22278543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.08.22278543</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmsdal G., Hanusson K.D., Kristiansen M.F., Foldbo B.M., Danielsen M.E., Steig B.&#xc1;., Gaini S., Strom M., Weihe P., Petersen M.S. Long COVID in the Long Run&#x2014;23-Month Follow-up Study of Persistent Symptoms. Open Forum Infect. Dis. 2024;9:ofac270. doi: 10.1093/ofid/ofac270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac270</ArticleId><ArticleId IdType="pmc">PMC9308378</ArticleId><ArticleId IdType="pubmed">35891696</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., Merle U. Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clin. Infect. Dis. 2021;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M., Xie Y., Topol E.J., Al-Aly Z. Three-year outcomes of post-acute sequelae of COVID-19. Nat. Med. 2024;30:1564&#x2013;1573. doi: 10.1038/s41591-024-02987-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-02987-8</ArticleId><ArticleId IdType="pmc">PMC11186764</ArticleId><ArticleId IdType="pubmed">38816608</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker S., Goodfellow H., Pookarnjanamorakot P., Murray E., Bindman J., Blandford A., Bradbury K., Cooper B., Hamilton F., Hurst J.R., et al. Impact of fatigue as the primary determinant of functional limitations among patients with post-COVID-19 syndrome: A cross-sectional observational study. BMJ Open. 2023;13:e069217. doi: 10.1136/bmjopen-2022-069217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-069217</ArticleId><ArticleId IdType="pmc">PMC10335413</ArticleId><ArticleId IdType="pubmed">37286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlile O., Briggs A., Henderson A.D., Butler-Cole B.F.C., Tazare J., Tomlinson L.A., Marks M., Jit M., Lin L.-Y., Bates C., et al. Impact of long COVID on health-related quality-of-life: An OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT) Lancet. 2024;40:100908. doi: 10.1016/j.lanepe.2024.100908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2024.100908</ArticleId><ArticleId IdType="pmc">PMC11059448</ArticleId><ArticleId IdType="pubmed">38689605</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Li X., Gu X., Zhang H., Ren L., Guo L., Liu M., Wang Y., Cui D., Wang Y., et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: A longitudinal cohort study. Lancet Respir. Med. 2022;10:863&#x2013;876. doi: 10.1016/S2213-2600(22)00126-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00126-6</ArticleId><ArticleId IdType="pmc">PMC9094732</ArticleId><ArticleId IdType="pubmed">35568052</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Palacios-Ce&#xf1;a D., G&#xf3;mez-Mayordomo V., Florencio L.L., Cuadrado M.L., Plaza-Manzano G., Navarro-Santanna M. Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis. Eur. J. Int. Med. 2021;92:55&#x2013;70. doi: 10.1016/j.ejim.2021.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkin A., Davison J., Tarrant R., Ross D., Halpin S., Simms A., Salman R., Sivan M. A Multidisciplinary NHS COVID-19 Service to Manage Post-COVID-19 Syndrome in the Community. J. Prim. Care. Comm. Health. 2021;12:1&#x2013;9. doi: 10.1177/21501327211010994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/21501327211010994</ArticleId><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Preston N., Parkin A., Makower S., Gee J., Ross D., Tarrant R., Davison J., Halpin S., O&#x2019;Connor R., et al. The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long COVID or Post-COVID-19 syndrome. J. Med. Virol. 2022;94:4253&#x2013;4269. doi: 10.1002/jmv.27878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27878</ArticleId><ArticleId IdType="pmc">PMC9348420</ArticleId><ArticleId IdType="pubmed">35603810</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A., Greenwood D., Horton M., Osborne T., Goodwin M., Lawrence R.R., Winch D., Williams P., Milne R., Sivan M. Psychometric analysis of the modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) in a prospective multicentre study. BMJ Open Respir. Res. 2024;11:e002271. doi: 10.1136/bmjresp-2023-002271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2023-002271</ArticleId><ArticleId IdType="pmc">PMC11086182</ArticleId><ArticleId IdType="pubmed">38724221</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Hout B., Janssen M.F., Feng Y.-S., Kohlmann T., Busschbach J., Golicki D., Lloyd A., Scalone L., Kind P., Pikard S. Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets. Value Health. 2012;15:708&#x2013;715. doi: 10.1016/j.jval.2012.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2012.02.008</ArticleId><ArticleId IdType="pubmed">22867780</ArticleId></ArticleIdList></Reference><Reference><Citation>Overview|Myalgic Encephalomyelitis (or Encephalopathy)/Chronic Fatigue Syndrome: Diagnosis and Management|Guidance|NICE.  [(accessed on 30 April 2024)].  Available online:  https://www.nice.org.uk/guidance/ng206.</Citation></Reference><Reference><Citation>Atchison C.J., Davies B., Cooper E., Lound A., Whitaker M., Hampshire A., Azor A., Donnelly A.A., Chadeau-Hyam M., Cooke G.S., et al. Long-term health impacts of COVID-19 among 242,712 adults in England. Nat. Commun. 2023;14:6588. doi: 10.1038/s41467-023-41879-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-41879-2</ArticleId><ArticleId IdType="pmc">PMC10598213</ArticleId><ArticleId IdType="pubmed">37875536</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nat. Med. 2023;29:2347&#x2013;2357. doi: 10.1038/s41591-023-02521-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T., Menges D., Anagnostopoulos A., Domenghino A., Aschmann H.E., Frei A., Fehr J.S., Puhan M.A. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: Population based, longitudinal cohort study. BMJ. 2023;381:e074425. doi: 10.1136/bmj-2022-074425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Soare I.-A., Ansari W., Nguyen J.L., Mendes D., Ahmed W., Atkinson J., Scott A., Atwell J.E., Longworth L., Becker F. Health-related quality of life in mild-to-moderate COVID-19 in the UK: A cross-sectional study from pre- to post-infection. HQOL. 2024;22:12. doi: 10.1186/s12955-024-02230-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-024-02230-5</ArticleId><ArticleId IdType="pmc">PMC10826014</ArticleId><ArticleId IdType="pubmed">38287294</ArticleId></ArticleIdList></Reference><Reference><Citation>Squire I., Glover J., Corp J., Haroun R., Kuzan D., Gielen V. Impact of HF on HRQoL in patients and their caregivers in England: Results from the ASSESS study. Br. J. Cardiol. 2017;24:30&#x2013;34. doi: 10.5837/bjc.2017.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.5837/bjc.2017.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Carney P., O&#x2019;boyle D., Larkin A., Mcguigan C., O&#x2019;rourke K. Societal costs of multiple sclerosis in Ireland. J. Med. Econ. 2018;21:425&#x2013;437. doi: 10.1080/13696998.2018.1427100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13696998.2018.1427100</ArticleId><ArticleId IdType="pubmed">29320900</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan C.M., Longworth L., Lord J., Canavan J.L., Jones S.E., Kon S.S.C., Man W.D.-C. The EQ-5D-5L health status questionnaire in COPD: Validity, responsiveness and minimum important difference. Thorax. 2016;71:493&#x2013;500. doi: 10.1136/thoraxjnl-2015-207782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2015-207782</ArticleId><ArticleId IdType="pmc">PMC4893131</ArticleId><ArticleId IdType="pubmed">27030578</ArticleId></ArticleIdList></Reference><Reference><Citation>Glasziou P., Alexander J., Beller E., Clarke P. Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial. HQOL. 2007;5:21. doi: 10.1186/1477-7525-5-21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-5-21</ArticleId><ArticleId IdType="pmc">PMC1950473</ArticleId><ArticleId IdType="pubmed">17462100</ArticleId></ArticleIdList></Reference><Reference><Citation>Janssen M.F., Pickard A.S., Shaw J.W. General population normative data for the EQ-5D-3L in the five largest European economies. Eur. J. Health Econ. 2021;22:1467&#x2013;1475. doi: 10.1007/s10198-021-01326-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10198-021-01326-9</ArticleId><ArticleId IdType="pmc">PMC8558182</ArticleId><ArticleId IdType="pubmed">34117986</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo N., Johnson J.A., Coons S.J. Using Instrument-Defined Health State Transitions to Estimate Minimally Important Differences for Four Preference-Based Health-Related Quality of Life Instruments. Med. Care. 2010;48:365&#x2013;371. doi: 10.1097/MLR.0b013e3181c162a2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MLR.0b013e3181c162a2</ArticleId><ArticleId IdType="pubmed">20355266</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Corral T., Fabero-Garrido R., Plaza-Manzano G., Navarro-Santana M.J., Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., L&#xf3;pez-De-Uralde-Villanueva I. Minimal Clinically Important Differences in EQ-5D-5L Index and VAS after a Respiratory Muscle Training Program in Individuals Experiencing Long-Term Post-COVID-19 Symptoms. Biomedicines. 2023;11:2522. doi: 10.3390/biomedicines11092522.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11092522</ArticleId><ArticleId IdType="pmc">PMC10526144</ArticleId><ArticleId IdType="pubmed">37760964</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C., Freitag H., Meyer-Arndt L., Wittke K., Hanitsch L.G., Zoller T., Steinbeis F., Haffke M., Rudolf G., Heidecker B., et al. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat. Commun. 2022;13:5104. doi: 10.1038/s41467-022-32507-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-32507-6</ArticleId><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Dorri J.A. ME/CFS and Post-Exertional Malaise among Patients with Long COVID. Neurol. Int. 2023;15:1&#x2013;11. doi: 10.3390/neurolint15010001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint15010001</ArticleId><ArticleId IdType="pmc">PMC9844405</ArticleId><ArticleId IdType="pubmed">36648965</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokumasu K., Honda H., Sunada N., Sakurada Y., Matsuda Y., Yamamoto K., Kakono Y., Hasegawa T., Yamamoto Y., Otsuka Y., et al. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID. Medicina. 2022;58:850. doi: 10.3390/medicina58070850.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58070850</ArticleId><ArticleId IdType="pmc">PMC9325226</ArticleId><ArticleId IdType="pubmed">35888568</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Hermosillo J.A., Mart&#xed;nez-L&#xf3;pez J.P., Carrillo-Lamp&#xf3;n S.A., Ruiz-Ojeda D., Herrera-Ram&#xed;rez S., Amezcua-Guerra L.M., Mart&#xed;nez-Alvarado M.D.R. Post-Acute COVID-19 Symptoms, a Potential Link with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A 6-Month Survey in a Mexican Cohort. Brain Sci. 2021;11:760. doi: 10.3390/brainsci11060760.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11060760</ArticleId><ArticleId IdType="pmc">PMC8227652</ArticleId><ArticleId IdType="pubmed">34201087</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Greenhalgh T., Darbyshire J.L., Mir G., O&#x2019;Connor R.J., Dawes H., Greenwood D., O&#x2019;Connor D., Horton M., Petrou S., et al. Long COVID Multidisciplinary consortium Optimising Treatments and servIces acrOss the NHS (LOCOMOTION): Protocol for a mixed-methods study in the UK. BMJ Open. 2022;12:e063505. doi: 10.1136/bmjopen-2022-063505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-063505</ArticleId><ArticleId IdType="pmc">PMC9114312</ArticleId><ArticleId IdType="pubmed">35580970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>